LivaNova PLC (NASDAQ:LIVN) Q2 2022 Earnings Conference Call August 3, 2022 8:00 AM ET
Company Participants
Matthew Dodds - SVP, Corporate Development
Damien McDonald - CEO & Director
Alex Shvartsburg - CFO
Conference Call Participants
Michael Polark - Wolfe Research
Frederick Wise - Stifel, Nicolaus & Company
Michael Matson - Needham & Company
Adam Maeder - Piper Sandler & Co.
Zachary Weiner - Jefferies
Anthony Petrone - Mizuho Americas
Operator
Good day, ladies and gentlemen, and welcome to the LivaNova PLC Second Quarter 202 Earnings Conference Call. [Operator Instructions]. As a reminder, this conference call is being recorded.
I would now like to introduce your host for today's conference, Mr. Matthew Dodds, LivaNova's Senior Vice President of Corporate Development. Please go ahead, sir.
Matthew Dodds
Thank you, Melissa, and welcome to our conference call and webcast discussing LivaNova's financial results for the second quarter of 2022. Joining me on today's call are Damien McDonald, our Chief Executive Officer; Alex Shvartsburg, our Chief Financial Officer; and Briana Gotlin, our newly appointed Director of Investor Relations. I am pleased to announce that Lindsey Little has been promoted and is moving back into the Finance group to work with Alex, and Briana is now heading Investor Relations. Before we begin, I would like to remind you that the discussions during this call will include forward-looking statements. Factors that could cause actual results to differ materially are discussed in the company's most recent financial filings and documents furnished to the SEC, including today's press release that is available on our website.
We do not undertake to update any forward-looking statement. Also, the discussions will include certain non-GAAP financial measures with respect to our performance, including, but not limited to, sales results, which will all be stated on a constant currency basis. Reconciliations to the most directly comparable GAAP financial measures can be found in today's press release, which is available on our website. We have also posted a presentation to our website that summarizes the points of today's call. This presentation is complementary to the other call materials and should be used as an enhanced communication tool. You can find the presentation and press release in the Investors section of our website under News Events and Presentations at investor.livanova.com. With that, I will now turn the call over to Damien.
Damien McDonald
Thank you, Matt, and thank you to everyone for joining us, and welcome to our conference call for the second quarter of 2022. I'll start by discussing our second quarter revenue results and reviewing our strategic portfolio initiatives. After my comments, Alex will provide additional details on our results, recent financing activities and an updated outlook. I will wrap up with closing comments before moving on to Q&A. In the quarter, we achieved 7% revenue growth, excluding heart valves. This was driven by year-over-year growth in cardiopulmonary and neuromodulation. Advanced regulatory support was unfavorably impacted by a significant decline in severe COVID cases and hospital staffing challenges.